SPOTLIGHT -
Nipocalimab receives Fast Track Designation to treat FNAIT
The FTD will allow the development and review timeline of nipocalimab to accelerate. It is granted to drugs with the potential to treat severe conditions and provide unmet vital medical needs.
Food Insecurity and the Dangers of Infant Formula Dilution
TNX-2900 to treat Prader-Willi syndrome granted Rare Pediatric Disease designation
TNX-2900 was previously granted Orphan Drug designation by the federal agency in 2022 for the treatment of PWS.
Demystifying Infant Formula
CDC: More measles cases reported in 2024 than all of 2023
As of March 21, 2024, 64 measles cases have been reported to the CDC by 17 jurisdictions.
Influenza, RSV, and COVID-19: Identifying determinants of hospitalization influence
The investigators concluded that age-related risk differences "highlight the necessity for tailored strategies, improving understanding of and treatment development for RVIs."